Tobias Hägglöv
Director of Finance/CFO chez ELEKTA AB
Fortune : 75 511 $ au 31/03/2024
Postes actifs de Tobias Hägglöv
Sociétés | Poste | Début | Fin |
---|---|---|---|
ELEKTA AB | Director of Finance/CFO | 01/02/2022 | - |
Historique de carrière de Tobias Hägglöv
Anciens postes connus de Tobias Hägglöv
Sociétés | Poste | Début | Fin |
---|---|---|---|
RECIPHARM AB (PUBL) | Director of Finance/CFO | 03/10/2018 | 01/01/2021 |
LEAX Group AB
LEAX Group AB Industrial MachineryProducer Manufacturing LEAX Group AB manufactures mechanical and electromechanical components and part systems. The firm offers business consultancy services, which include implementation of management, quality, and environmental systems and project management services. The company was founded in 1984 and is headquartered in Koping, Sweden. | Director of Finance/CFO | 01/01/2017 | 01/01/2018 |
ELECTROLUX AB | Public Communications Contact | 01/01/2008 | 01/01/2012 |
Corporate Officer/Principal | 01/01/2012 | 01/01/2017 | |
Scandinavian Airlines System SAS | Investor Relations Contact | 01/01/2007 | 01/01/2008 |
Formation de Tobias Hägglöv
University of Stockholm | Graduate Degree |
Royal Institute of Technology | Graduate Degree |
Statistiques
Internationale
Suède | 8 |
Opérationnelle
Director of Finance/CFO | 3 |
Graduate Degree | 2 |
Public Communications Contact | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 3 |
Consumer Durables | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ELECTROLUX AB | Consumer Durables |
ELEKTA AB | Health Technology |
Entreprise privées | 3 |
---|---|
Recipharm AB
Recipharm AB BiotechnologyHealth Technology Recipharm AB engages in the manufacture of pharmaceuticals and contract development services for pharmaceutical companies. It operates through the following segments: Manufacturing Sterile and Inhalation (MFG-SI); Manufacturing Solids and Others (MFG-SO); Development and Technology (D&T); and Others and Eliminations. The MFG-SI segment includes manufacturing of products on behalf of pharmaceutical companies and covers sterile and inhalation technologies as well as liquid vials and ampoules, lyophilisates, blow-fill-seal products, and inhalation. The MFG-SO segment produces products on behalf of pharmaceutical companies and covers tablets, capsules, semi-solids, and non-sterile liquids. The D&T segment focuses on pharmaceutical development services. The company was founded by Lars Rickard Backsell and Thomas Bengt Eldered in 1995 and is headquartered in Stockholm, Sweden. | Health Technology |
LEAX Group AB
LEAX Group AB Industrial MachineryProducer Manufacturing LEAX Group AB manufactures mechanical and electromechanical components and part systems. The firm offers business consultancy services, which include implementation of management, quality, and environmental systems and project management services. The company was founded in 1984 and is headquartered in Koping, Sweden. | Producer Manufacturing |
Scandinavian Airlines System SAS | Transportation |
- Bourse
- Insiders
- Tobias Hägglöv
- Expérience